STOCK TITAN

CinCor Pharma to Present at Upcoming Piper Sandler and Evercore ISI Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

CinCor Pharma announced participation in two investor conferences in late November 2022. The first is the Piper Sandler 34th Annual Healthcare Conference, held from November 29 to December 1, with a presentation on November 29 at 1:30 PM EST in New York. The second is the Evercore ISI 5th Annual HealthCONx Conference, taking place virtually from November 30 to December 1, featuring a presentation on December 1 at 3:30 PM EST. Archived replays will be available on their website.

Positive
  • None.
Negative
  • None.

WALTHAM, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (NASDAQ: CINC) today announced that company management will present at the following investor conferences in November:

Event:Piper Sandler 34th Annual Healthcare Conference
Date:November 29 – December 1, 2022
Location:Lotte New York Palace in New York, New York
Presentation:Tuesday, November 29, 2022 at 1:30pm EST
Webcast:https://event.webcasts.com/starthere.jsp?ei=1585686&tp_key=3261cabcd6
  
Event:Evercore ISI 5th Annual HealthCONx Conference
Date:November 30 – December 1, 2022
Location:Virtual
Presentation:Thursday, December 1, 2022 at 3:30pm EST
Webcast:https://wsw.com/webcast/evercore29/cinc/2336910

The CinCor management team will participate in one-on-one investor meetings during these events. Investors interested in meeting with CinCor at the conference should contact their Piper Sandler or Evercore ISI representative. An archived replay of the presentations will be available for 90 days at CinCor.com/events.

About CinCor
CinCor, founded in 2018, is a clinical-stage biopharmaceutical company with a mission to bring innovation to the pharmaceutical treatment of cardio-renal diseases. Its lead asset, baxdrostat, a highly selective, oral small molecule inhibitor of aldosterone synthase, is in clinical development for the treatment of hypertension and primary aldosteronism.

Contacts: Investors:
Michael KalbBob Yedid
CinCor Pharma, Inc.LifeSci Advisors
EVP and CFO  ir@CinCor.com

FAQ

When is CinCor's presentation at the Piper Sandler conference?

CinCor Pharma will present at the Piper Sandler 34th Annual Healthcare Conference on November 29, 2022, at 1:30 PM EST.

When will CinCor present at the Evercore ISI conference?

CinCor will present at the Evercore ISI 5th Annual HealthCONx Conference on December 1, 2022, at 3:30 PM EST.

Where can I watch CinCor's investor presentations?

Archived replays of CinCor's presentations will be available for 90 days on their website at CinCor.com/events.

What are the dates for the Piper Sandler conference?

The Piper Sandler 34th Annual Healthcare Conference is scheduled for November 29 to December 1, 2022.

Is CinCor's presentation at the Evercore ISI conference virtual?

Yes, CinCor's presentation at the Evercore ISI 5th Annual HealthCONx Conference will be held virtually.

CINC

NASDAQ:CINC

CINC Rankings

CINC Latest News

CINC Stock Data

Medicinal and Botanical Manufacturing
Manufacturing
Link